Aftab Kherani - Profile and Investment Details

Investor Profile

Aftab Kherani is a Venture Capital, Private Equity Firm based in New York City, New York, United States with a diverse investment portfolio that includes companies such as Zeltiq Aesthetics, Dermira, Cortica, Spruce Biosciences, Syros Pharmaceuticals, XII Medical, Asensus Surgical, Esperion Therapeutics, F2G, T2 Biosystems, Eidos Therapeutics, Versartis, TRIA Beauty, Nuvation Bio, Xanodyne, Seragon PharmaceuticalsSpirox, Verona Pharma, Ablacon, Inc., Avrobio, Talaris Therapeutics, Bioenvision, Miramar Labs, GTx, Spirox, Inc., Sirion Therapeutics, Cempra, Ambit Biosciences, CeNeRx BioPharma, BridgeBio, NextWave Pharmaceuticals, Pharmaron Holding, Topaz Pharmaceuticals Inc, Loxo Oncology, Treeline Biosciences, Elevation Oncology, Bridge Pharmaceuticals, Natural Dentist, Reneo Pharmaceuticals, Atreca, Aclaris Therapeutics, Promentis Pharmaceuticals, Agile Therapeutics, Biohaven Pharmaceutical, BioRelix, Cytos, Biomea Fusion, Ajax Health, Monte Rosa Therapeutics, ViewRay, Poseida Therapeutics, PowerVision, Cynapsus Therapeutics, VYNE Therapeutics, Cidara Therapeutics, Paratek Pharmaceuticals, Bristol-Myers Squibb, Aimmune Therapeutics, LensAR, LOXO Oncology, Inc., Earlens Corporation, Arcus Biosciences, Roka Bioscience, ObsEva, TransEnterix, Inc, Aragon Pharmaceuticals, Prolacta Bioscience, . Over time, Aftab Kherani has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Aftab Kherani is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Business Model Innovation, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Finance, Manufacturing, Biotechnology, Medical Devices, Innovation, Digital Health, Medical, Information Technology, B2B, Therapeutics, Health Tech, Pharmaceuticals may find it worthwhile to explore potential connections with Aftab Kherani, as their portfolio suggests a familiarity and interest in this area.

Understanding Aftab Kherani’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.